Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall

Hasbro (HAS) PT Raised to $64 at Citi

Citi analyst James Hardiman raised the price target on Hasbro (NASDAQ: HAS) to $64.00 (from $52.00) while maintaining a Neutral rating.

The analyst comments "HAS shares were up 12% in Wednesday trading (vs. flat S&P) as (1) a sizable beat in the context of a... More

Humana (HUM) PT Lowered to $353 at RBC Capital

RBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.

The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More

Fortive (FTV) PT Lowered to $83 at RBC Capital

RBC Capital analyst Deane Dray lowered the price target on Fortive (NYSE: FTV) to $83.00 (from $93.00) while maintaining a Sector Perform rating.

The analyst comments "Sector Perform-rated Fortive reported a modest 3c/4% 1Q24 operating beat on higher organic revenues/margins. 2024 guidance was tweaked 0.5%... More

Biogen (BIIB) PT Lowered to $317 at RBC Capital

RBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $317.00 (from $326.00) while maintaining a Outperform rating.

The analyst comments "Some encouraging signs for the launch products Skyclarys, Leqembi, and Zurzuvae; while the base business remains pressured and a more... More

AT&T (T) PT Raised to $18 at RBC Capital

RBC Capital analyst Jon Atkin raised the price target on AT&T (NYSE: T) to $18.00 (from $17.00) while maintaining a Sector Perform rating.

The analyst comments "1Q revenue was just shy of consensus (on a shortfall in wireless equipment revenues), while EBITDA... More

Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald

Cantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.

The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More

Meta Platforms Inc. (META) PT Raised to $562 at Rosenblatt, 'Squishy-ish guidance'

Rosenblatt analyst Barton Crockett raised the price target on Meta Platforms Inc. (NASDAQ: META) to $562.00 (from $520.00) while maintaining a Buy rating.

The analyst comments "Squishy-ish guidance -- The revenue growth outlook for 2Q24 -- up 14% to 22% Y/Y -- is strong, but decelerating, reflective of comps that get 8 percentage points tougher Q/Q, and also of a 3 percentage point tougher foreign exchange backdrop and the lack of 1Q24's... More

Meta Platforms Inc. (META) PT Raised to $520 at MoffettNathanson, 'a more attractive entry point for Meta investors'

MoffettNathanson analyst Michael Nathanson raised the price target on Meta Platforms Inc. (NASDAQ: META) to $520.00 (from $185.00) while maintaining a Buy rating.

The analyst comments "Management guided to second quarter 2024 revenues in the range of $36.5 to $39 billion, which at the midpoint of $37.75 billion implies year-over-year growth of +18%. Yes, that is a marked deceleration from the... More

Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank

Deutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $610.00 (from $600.00) while maintaining a Buy rating.

The analyst comments "Messaging around bioprocessing was concise but positive, as order growth and book-to-bill continue to trend higher. We are... More

Tesla (TSLA) PT Raised to $136 at Deutsche Bank

Deutsche Bank analyst Emmanuel Rosner raised the price target on Tesla (NASDAQ: TSLA) to $136.00 (from $123.00) while maintaining a Hold rating.

The analyst comments "The strong positive market reaction to Teslas mixed Q1 print, in our view represented some relief that Tesla is not completely giving up on selling... More

Old Dominion Freight Line (ODFL) PT Lowered to $225 at Evercore ISI

Evercore ISI analyst Jonathan Chappell lowered the price target on Old Dominion Freight Line (NASDAQ: ODFL) to $225.00 (from $241.00) while maintaining a Outperform rating.

The analyst comments "ODFL posted 1Q24 EPS of $1.34, coming in exactly in-line with the average Street forecast and $0.03 below... More

Meta Platforms Inc. (META) PT Lowered to $500 at Deutsche Bank

Deutsche Bank analyst Leo Horowitz lowered the price target on Meta Platforms Inc. (NASDAQ: META) to $500.00 (from $540.00) while maintaining a Buy rating.

The analyst comments "Meta is entering an investment cycle. We have been here a couple of times before, and each time it ended the same waygood for META's longer-term equity value. This time, Meta is making bigger investments in AI than we anticipated, which will likely result in Capex being much higher, for far... More

Meta Platforms Inc. (META) PT Raised to $510 at Roth/MKM, 'Buy On Weakness; AI Moat Now Deeper'

Roth/MKM analyst Rohit Kulkami raised the price target on Meta Platforms Inc. (NASDAQ: META) to $510.00 (from $500.00) while maintaining a Buy rating.

The analyst comments "META shares were down as much as -15% last night despite a clean beat on 1Q expectations and... More

Goldman Sachs on Boeing (BA): 'There's a path back to normal'

Goldman Sachs analyst Noah Poponak reiterated a Buy rating and $243.00 price target on Boeing (NYSE: BA)

The analyst comments "Boeing articulated an expectation that major aircraft delivery disruption from its product quality improvement initiatives look contained to first half 2024, the company then... More

Boeing (BA) PT Lowered to $224 at Citi

Citi analyst Jason Gursky lowered the price target on Boeing (NYSE: BA) to $224.00 (from $252.00) while maintaining a Buy rating.

The analyst comments "1Q results were better than expected, with revenue, EPS and FCF all coming in better than consensus estimates.... More

Meta Platforms Inc. (META) PT Lowered to $570 at RBC Capital

RBC Capital analyst Brad Erickson lowered the price target on Meta Platforms Inc. (NASDAQ: META) to $570.00 (from $600.00) while maintaining a Outperform rating.

The analyst comments "META's Q1 was solid in terms of top-line/ad demand trends - the issue is an accelerated, multi-year AI... More

Evercore ISI Believes Meta Platforms Inc. (META) is Down Due to High Expectations into the Print

Evercore ISI analyst Mark Mahaney reiterated an Outperform rating and $550.00 price target on Meta Platforms Inc. (NASDAQ: META).

The analyst comments "Quick Look At Q1 Results: META printed a Beat & Bracket quarter, with Revenue up 27% Y/Y (both reported basis and ex-FX), 1% above the Street, Op Income (implying 37.9% margin) 4% above the Street, and EPS at... More

Boeing (BA) PT Lowered to $240 at Stifel

Stifel analyst Bert Subin lowered the price target on Boeing (NYSE: BA) to $240.00 (from $260.00) while maintaining a Buy rating.

The analyst comments "Boeing reported 1Q adj-EPS of ($1.13) and ($3.9B) in FCF, which were ahead of expectations as were sales. 1Q results... More

JPM sees risk of further negative earnings revisions for Tesla (TSLA)

Following Tesla's (NASDAQ: TSLA) first-quarter 2024 results, JPMorgan has raised concerns over the possibility of additional negative earnings revisions and ongoing multiple compression for the electric vehicle giant.

The earnings report showed softer performance than anticipated, with revenue for the quarter totaling $21.3 billion, slightly below JPMorgan's estimate of $21.4 billion. However, this figure fell notably short of the Bloomberg consensus of $22.3 billion, which had progressively declined from $25.7 billion following the fourth-quarter 2023... More

Jefferies Downgrades Enphase Energy (ENPH) to Hold, 'Still Muddling Through'

Jefferies analyst Dushyant Ailani downgraded Enphase Energy (NASDAQ: ENPH) from Buy to Hold with a price target of $111.00 (from $135.00).

The analyst comments "We are downgrading ENPH, as we expect resi macro headwinds to persist. Mgmt continues to take the right steps in managing under... More

JPMorgan First Take on Biogen (BIIB)

JPMorgan analyst Chris Schott reiterated a Neutral rating on Biogen (NASDAQ: BIIB).

The analyst comments "This morning, BIIB reported 1Q results that were in line on the top line (Spinraza miss/Tecfidera beat) and ahead on the bottom line and the company... More

JPMorgan on Tesla (TSLA): 'See Risk of Further Negative Earnings Revisions'

JPMorgan analyst Ryan Brinkman reiterated an Underweight rating and $115.00 price target on Tesla (NASDAQ: TSLA).

The analyst comments "We see the risk of further negative earnings revisions and continued multiple compression after 1Q24 results tracked softer even than estimates that had recently been... More

Visa (V) PT Raised to $300 at Macquarie

Macquarie analyst Paul Golding raised the price target on Visa (NYSE: V) to $300.00 (from $290.00) while maintaining a Outperform rating.

The analyst comments "Beats across key metrics, thanks to stability of US consumers. We extrapolate the resilience of higher income consumers driving... More

Bernstein on Tesla: 'Widespread deployment of FSD is 5 - 10 years away'

With Tesla (NASDAQ: TSLA) back to being all in on autonomy, analysts at Bernstein said in a note Wednesday that they believe widespread deployment of Full-Self Driving (FSD) is five to ten years away.

Tesla reported its latest quarterly earnings on Tuesday after the close, missing consensus estimates.

Bernstein acknowledged that Elon has a long history of being overly... More

BMO Capital First Take on Biogen (BIIB) Earnings

BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $260.00 price target on Biogen (NASDAQ: BIIB).

The analyst comments "Topline miss countered by operating expense efficiency gains from "Fit for Growth" initiative. Topline miss (-1% vs. cons.) mostly driven by Spinraza... More